Role of Tumor-Derived Granulocyte-Macrophage Colony-Stimulating Factor in MiceBear ing a Highly Invasive and Metastatic Mammary Carcinoma
- 1 January 1999
- journal article
- research article
- Published by S. Karger AG in Pathobiology
- Vol. 67 (4) , 180-185
- https://doi.org/10.1159/000028070
Abstract
We have examined the role of granulocyte-macrophage colony-stimulating factor (GM-CSF) in tumor-bearing BALB/c mice using the syngeneic F3II mammary carcinoma. In the present model, progression of subcutaneous tumors induced massive myelopoiesis in bone marrow and spleen due to GM-CSF secretion by tumor cells. In vitro, the addition of recombinant mouse GM-CSF (5– 25 ng/ml) caused a significant increase in F3II cell growth, either in the presence or absence of serum. Zymographic analysis of conditioned media from F3II monolayers showed that GM-CSF exerted a dose-dependent enhancement in the metalloproteinases MMP-9 (105 kD) and MMP-2 (70 kD), key enzymes in mammary tumor cell invasion. Our data suggest that ectopic GM-CSF production stimulates myelopoiesis and may also play an important role in tumor progression and metastasis formation.Keywords
This publication has 5 references indexed in Scilit:
- CTLA-4 blockade synergizes with tumor-derived granulocyte– macrophage colony-stimulating factor for treatment of an experimental mammary carcinomaProceedings of the National Academy of Sciences, 1998
- Granulocyte‐macrophage‐colony stimulating factor stimulates tumor invasiveness in squamous cell lung carcinomaCancer, 1998
- Expression and function of colony-stimulating factors and their receptors in human prostate carcinoma cell linesThe Prostate, 1998
- 72-kD (MMP-2) and 92-kD (MMP-9) Type IV Collagenase Production and Activity in Different Histologic Types of Lung Cancer CellsPathobiology, 1998
- Characterization of F3II, a sarcomatoid mammary carcinoma cell line originated from a clonal subpopulation of a mouse adenocarcinomaJournal of Surgical Oncology, 1996